//]]>

Green and Sustainable Pharmacy (Record no. 24468)

000 -LEADER
fixed length control field 04465nam a22004935i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310152328.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100623s2010 gw | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783642051999
978-3-642-05199-9
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number GE300-350
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 333.7
Edition number 23
264 #1 -
-- Berlin, Heidelberg :
-- Springer Berlin Heidelberg :
-- Imprint: Springer,
-- 2010.
912 ## -
-- ZDB-2-EES
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kümmerer, Klaus.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Green and Sustainable Pharmacy
Medium [electronic resource] /
Statement of responsibility, etc edited by Klaus Kümmerer, Maximilian Hempel.
300 ## - PHYSICAL DESCRIPTION
Extent XVII, 313 p.
Other physical details online resource.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note General Aspects -- Why Green and Sustainable Pharmacy? -- Pharmaceuticals in the Environment: Moving from a Problem to a Solution -- Pharmaceuticals in Society -- Green(er) Pharmacy -- Creating a Sustainability Culture – A (Human Resources) Management Perspective for Sustainable Pharmacy -- Reducing the Ecological Footprint of Pharmaceutical Usage: Linkages Between Healthcare Practices and the Environment -- Development, Synthesis and Production and Distribution of Pharmaceuticals -- Ecopharmacostewardship – A Pharmaceutical Industry Perspective -- Protein and Peptide Therapeuticals: An Example of “Benign by Nature” Active Pharmaceutical Ingredients -- Rational Design of Molecules by Life Cycle Engineering -- Use and Disposal of Pharmaceuticals -- Options for a More Environmentally Friendly Handling of Pharmaceuticals -- Disposal of Pharmaceutical Waste in Households – A European Survey -- Pharmaceutical Waste: The Patient Role -- Forecast of Pharmaceutical Consumption in the Netherlands Using Demographic Projections -- Emission Management -- Point Sources of Human Pharmaceuticals into the Aquatic Environment -- Pharmaceuticals for Human Use: An Integrated Strategy for Reducing the Contamination of Water Bodies -- Experiences with the Swedish Environmental Classification Scheme -- Incentives, Regulation and the Market -- European Regulations -- Regulation and the Market-Incentives -- Do Pharmaceuticals in the Environment Present an Investment Risk? -- Outlook -- Sustainable Health Products and Service Solutions in the Year 2050 -- Summary and Outlook.
520 ## - SUMMARY, ETC.
Summary, etc Within recent years pharmaceuticals have come into focus as contaminants of the environment (see for example Kümmerer, K. editor: Pharmaceuticals in the Environment). At the same time the issue of sustainable chemistry gained momentum. Bringing both together would result in sustainable pharmacy. Sustainable pharmacy is a totally new issue and approach. It addresses environmental, economical and social aspects of pharmacy. In the present stage the focus will be on environmental issues along the whole lifecycle of a pharmaceutical entity. That is dealing with resources and energy input but also with waste issues for example during the synthesis and production of an active pharmaceutical ingredient. Furthermore, it would also look on the compounds themselves and will aim to improve the degradability of the compounds after their use in the environment to reduce the environmental risk caused by pharmaceuticals in the environment. Another issue is the people using pharmaceuticals such as pharmacists, medical doctors and patients. How can they contribute to more efficient use of pharmaceuticals with less environmental burden and less risk for drinking water. The book "Sustainable Pharmacy" will address all these issues and will be the first one dealing with this important topic.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Environmental sciences.
Topical term or geographic name as entry element Biochemistry.
Topical term or geographic name as entry element Pharmacy.
Topical term or geographic name as entry element Environmental management.
Topical term or geographic name as entry element Environmental toxicology.
Topical term or geographic name as entry element Sustainable development.
Topical term or geographic name as entry element Environment.
Topical term or geographic name as entry element Environmental Management.
Topical term or geographic name as entry element Pharmacy.
Topical term or geographic name as entry element Medicinal Chemistry.
Topical term or geographic name as entry element Ecotoxicology.
Topical term or geographic name as entry element Sustainable Development.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hempel, Maximilian.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9783642051982
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-3-642-05199-9
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-08AUM Main Library2014-04-08 2014-04-08 E-Book   AUM Main Library333.7